Trials / Completed
CompletedNCT02918630
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess if access to an electronic nicotine delivery device, or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking among individuals diagnosed with schizophrenia compared to nicotine patch alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine Patch | Participants will receive nicotine patch (21 mg) starting study Week 1. Participants will be instructed to apply a new patch each morning. |
| DRUG | E-cigarette | The e-cigarette will consist of 1) a 3.3 V, 1000 mAh battery; and 2) a 1.5 Ohm, dual-coil cartomizer (SmokTech; Shenzhen, China). Study staff will load the cartomizer with 1 ml tobacco flavored 70% propylene glycol/30% vegetable glycerin liquid containing nicotine concentrations 36 mg/ml (AVAIL; Richmond, Virginia, USA). |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2016-09-29
- Last updated
- 2018-07-05
- Results posted
- 2018-07-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02918630. Inclusion in this directory is not an endorsement.